Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
- Chemotherapy for Waldenstrom Macroglobulinemia
- Targeted Drug Therapy for Waldenstrom Macroglobulinemia
- Biological Therapy or Immunotherapy for Waldenstrom Macroglobulinemia
- Plasmapheresis (Plasma Exchange) for Waldenstrom Macroglobulinemia
- Stem Cell Transplant for Waldenstrom Macroglobulinemia
- Radiation Therapy for Waldenstrom Macroglobulinemia
- When to Treat People with Waldenstrom Macroglobulinemia
- References: Waldenstrom Macroglobulinemia
- If You Have Waldenstrom Macroglobulinemia
What Are the Risk Factors for Waldenstrom Macroglobulinemia?
A risk factor is anything that affects your chance of getting a disease such as cancer. Different cancers have different risk factors. Some cancer risk factors, like smoking, can be changed. Others, like a person’s age or family history, can’t be changed.
Researchers have found a few risk factors that make a person more likely to develop Waldenstrom macroglobulinemia (WM). But most people with these risk factors never develop WM.
Monoclonal gammopathy of undetermined significance (MGUS)
Monoclonal gammopathy of undetermined significance (MGUS) is an abnormality of antibody-making cells that is related to multiple myeloma and WM. In MGUS, like WM and multiple myeloma, abnormal cells in the bone marrow make large amounts of one particular antibody. This antibody is called a monoclonal (or M) protein, and the condition is called a monoclonal gammopathy.
- As long as the patient has no symptoms from the abnormal cells or the M protein they make, the abnormal cells make up less than 10% of the bone marrow, and the amount of abnormal M protein in the blood is not very high (less than 3 g/dl), this condition is called MGUS.
- MGUS itself does not cause health problems, but each year about 1% to 2% of people with MGUS go on to develop a related cancer (like multiple myeloma, WM, or lymphoma) or another serious health problem (like amyloidosis).
Age
The risk of WM goes up with age. It is rare among people younger than 50 years old.
Race
WM is more common among White people than among African Americans. In contrast, multiple myeloma is about twice as common among African Americans as White Americans. The reasons for these differences are not known.
Sex
Men are more likely than women to develop this disease. The reason for this is not known.
Heredity
Inherited genes seem to play a role in at least some people who get WM. About 1 in 5 people with WM has a close relative with WM or with a related B-cell disease, such as MGUS or certain types of lymphoma or leukemia.
Hepatitis C
Hepatitis C is caused by infection with a virus (known as the hepatitis C virus, or HCV). Some studies have found that people with chronic hepatitis C infection might be more likely to develop WM than people without the virus. But not all studies have found such a link.
Certain autoimmune diseases
Some research has suggested that people with certain types of autoimmune disease, such as Sjögren (Sjogren) syndrome, might be at higher risk for WM.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
Castillo JJ. Plasma cell disorders. Prim Care. 2016; 43:667-691. doi: 10.1016/j.pop.2016.07.002. Epub 2016 Oct 14.
Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA. 2007;297:2010–2017.
Kristinsson SY, Koshiol J, Björkholm M, et al. Immune-Related and Inflammatory Conditions and Risk of Lymphoplasmacytic Lymphoma or Waldenström Macroglobulinemia. JNCI Journal of the National Cancer Institute. 2010;102(8):557-567. doi:10.1093/jnci/djq043.
Rajkumar SV, Dispenzieri A. Chapter 104: Multiple myeloma and related disorders. In: Niederhuber JE, Armitage JO, Dorshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia, Pa. Elsevier: 2014.
Last Revised: July 19, 2018
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.